The current PE ratio of DVAX cannot be calculated, as the latest EPS of -$0.05 is negative. The last PE ratio of Dynavax Technologies, recorded in September 2023, was 30.77.
The PE ratio of Dynavax Technologies has averaged 12.66 over the last three years. Looking back at the last three years, DVAX's PE ratio peaked in the Sep 2023 quarter at 30.77, when the price was $14.77 and the EPS was $0.48. The lowest point was in the Sep 2022 quarter, when it reached 4.02 with a price of $10.44 and an EPS of $2.6.
Maximum annual decrease: -79.77% in 2022
| Year | PE ratio | Change |
|---|---|---|
| 2023 | N/A | N/A |
| 2022 | 4.59 | -79.77% |
| 2021 | 22.69 | N/A |
| 2020 | N/A | N/A |
| 2019 | N/A | N/A |
| 2018 | N/A | N/A |
| 2017 | N/A | N/A |
| 2016 | N/A | N/A |
| 2015 | N/A | N/A |
| 2014 | N/A | N/A |
| Stock name | PE ratio | Market cap |
|---|---|---|
| GILD Gilead Sciences Inc | 14.41 | $81.5B |
| AMGN Amgen Inc | 21.5 | $144.69B |
| BIIB Biogen Inc | 25.95 | $30.42B |
| AZN Astrazeneca plc | 36.67 | $233.05B |
| PFE Pfizer Inc | 66.84 | $143.43B |
| MRK Merck & Co Inc | 937.14 | $332.28B |
| AGEN Agenus Inc | N/A | $244.86M |
| TEVA Teva Pharmaceutical Industries Ltd | N/A | $15.48B |
| DVAX Dynavax Technologies Corp | N/A | $1.46B |
The current price to earnings ratio of DVAX cannot be determined, as its EPS of -$0.05 is negative.
As an average over the last 3 years, DVAX stock has a PE ratio of 12.66.
As an average over the last 5 years, DVAX stock has a PE ratio of 12.66.
The highest quarterly PE ratio in the last three years has been 30.77 and it was in the Sep 2023 quarter.
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.